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B-cell lymphoproliferative diseases are a group of
similar disorders that have particular clinical and laboratory
characteristics. The most representative is classic chronic
lymphoid leukemia (CLL).1
CLL is a heterogeneous disease that affects elderly
patients with three to five cases for every 100 million people
per year however this number rises to 20 cases per 100
million in over 70-year-old individuals; thus it is the most
common leukemia in Western countries. The number of cases
of the disease is increasing partly because of changes in
the habits of the population, but mainly due to the reduction
in the minimum number of peripheral lymphocytes used in
its diagnosis.2-5 The diagnosis of CLL and the differential
diagnosis of chronic lymphoproliferative syndromes
depends largely on laboratory tests and immuno-
phenotyping. Cytogenetic and molecular studies are
fundamental to the study of these diseases and in treating
patients LLC.6 Besides the classical clinical stages, such as
Rai and Binet, the immunoglobulin variable heavy chain
(IgVH) mutational status,7 ZETA-associated protein-70
(ZAP-70)8 and genomic aberrations6 are important predictors
that guide the treatment of patients. In the clinical practice,
we are used to seeing patients in a good general condition,
asymptomatic, often with symmetrical nodes and spleen,
but with a need to find an explanation for leukocytosis
associated with lymphocytosis in peripheral blood. The
conventional microscopy technique consists of
morphologically normal lymphocytes and Gumprecht spots,
rejecting the possibility of a technical artifact thereby
diagnosing classical LLC or suspicion of a chronic lympho-
proliferative disease.
In this issue of the Brazilian Journal of Hematology and
Hemotherapy, Matos and colleagues9 remind us of the history
of hematology, of the trivial but important nuclear shadow or
Gumprecht cells as have been cited in works since 1896.
Whether the presence of Gumprecht cells is tantamount to
the diagnosis of CLL was determined by analyzing 125
patients predominantly with the diagnosis of CLL and patients
with other B cell lymphoproliferative diseases. Systematically
they try to gauge the existence of a percentage cut off point
(10, 20 or 30%) for the differential diagnosis between B cell
lymphoproliferative disorders and CLL and concluded that
this myth in the hematological clinical practice is not
supported by the observed data.
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